InvestorsHub Logo
Followers 5
Posts 224
Boards Moderated 0
Alias Born 03/19/2015

Re: Fabio78 post# 261622

Friday, 04/03/2020 8:57:27 PM

Friday, April 03, 2020 8:57:27 PM

Post# of 425847
I have now read the full thing. I have to say say again first that I am not a lawyer, but it really felt as the judge was placing excessive burden of proof to Amarin vs generics.

IN particular I find very troublesome that she finds 2 of the secondary considerations favoring Amarin and still invalidated the patents.

I simply do not see clearly that defendant has proven that the patent are obvious when everything (including secondary considerations) are evaluated together. I look forward to HDGabor analysis who I have a great respect for, but my own analysis is that Amarin has a significant chance of success on the appeal


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News